Abstract:Background CD47,knownasintegrin-associatedreceptorprotein,isover-expressed onnon-small-celllungcancer(NSCLC)cells.Itcaninteractwithsignalregulatory protein-a(SIRPa)andinhibitmacrophagephagocytosis.Autophagy,akeyingredient in microenvironment maintenance, plays a critical role in tumorigenesis, tumor development and metastasis. Here, we report a potential approach for NSCLC therapy by targeting both CD47 and autophagy. Background ClusterofDifferentiation(CD47),knownasintegrin-associatedreceptor protein,isover-expressedonnon-small-celllungcancer(NSCLC)cells.Itcaninteract withsignalregulatoryprotein-alpha(SIRPa)andinhibitmacrophagephagocytosis. Autophagy, a key ingredient in microenvironment maintenance, plays a critical role in tumorigenesis, tumor development and metastasis. Here, we report a potential approach for NSCLC therapy by blocking both CD47 and autophagy. Methods A novel fusion protein named SIRPa-Fc was prepared and employed to target CD47onNSCLCcells.Threestandardtechniquesincludingconfocalmicroscope, transmission electron microscope and western blots were used to detect the autophagy in NSCLC cells after CD47 blockade. LDH-release and CFSE staining assay were appliedtodetectthephagocytosisofNSCLCcellsafterblockadeofCD47/autophagy. NSCLC xenograft models were established in BALB/c nude mice to investigate the anti- tumoreffectoftargetingbothCD47andautophagyinNSCLC. Methods A novel fusion protein named SIRPa-Fc was prepared and employed to block CD47onNSCLCcells.Threestandardtechniquesincludingtransmissionelectron microscope, confocal microscope and western blot were used to detect autophagy in NSCLCcellsafterCD47blockade.LDH-releaseandCFSEstainingassaywereapplied todetectthephagocytosisofNSCLCcellsafterblockadeofCD47/autophagy.NSCLC xenograft models were established in BALB/c nude mice to investigate the anti-tumor effectofblockingbothCD47andautophagyinNSCLC. Results WefoundthatblockingCD47couldincreasethephagocytosisandcytotoxicity ofmacrophageagainstNSCLCcells.Duringthisprocess,autophagywastriggered, which was characterized by the three main stages ofautophagic fluxincluding: formation and accumulation ofautophagosomes, fusion ofautophagosomes into lysosomesanddegradationofautophagosomesinlysosomes.Importantly,inhibitionof autophagyinNSCLCcellscouldnotablyenhancetheeffectofCD47blockadeon macrophage-mediatedcytotoxicity,whileco-suppressionofautophagyandCD47 signalingcouldalsoelicitpotentanti-NSCLCefficacyinvivo. Results WefoundthatblockingCD47couldincreasethephagocytosisofmacrophage against NSCLC cells. During this process, autophagy was triggered, which was characterized by the three main stages ofautophagic fluxincluding: formation andaccumulationofautophagosomes,fusionofautophagosomesintolysosomes anddegradationofautophagosomesinlysosomes.Importantly,inhibitionof autophagyinNSCLCcellscouldnotablyenhancetheeffectofCD47blockadeon macrophage-mediatedphagocytosis, whileco-suppressionofautophagyandCD47 signalingcouldalsoelicitenhancedanti-NSCLCefficacyinvivo. Conclusions We demonstrated that autophagy was induced in NSCLC cells after CD47 blockade,whileinhibitionofautophagycouldsignificantlyenhancetheanti-tumor efficacyofCD47blockadeinNSCLCs.Ourdataelucidatedthecriticalroleofautophagy inCD47abolishment-basedNSCLStherapyandhighlightedthepotentialapproachfor thetreatmentofNSCLCbyblockingautophagyandCD47. Legal entity responsible for the study N/A Funding the National Natural Science Foundation ofChina (81573332) Disclosure All authors have declared no conflicts ofinterest.

Blocking CD47 promotes anti-tumor immunity through CD103+ dendritic cell-NK cell axis in murine hepatocellular carcinoma model

Blocking CD47 Promotes Antitumour Immunity Through CD103+ Dendritic Cell-Nk Cell Axis in Murine Hepatocellular Carcinoma Model.

CD47 Blockade Triggers T Cell–mediated Destruction of Immunogenic Tumors

CD47 Masks Pro-Phagocytic Ligands in Cis on Tumor Cells to Suppress Antitumor Immunity

CD47-SIRPα axis restricts the therapeutic antitumor immunity through controlling tumor mitochondrial DNA-mediated innate sensing selectively in dendritic cells

Abstract A047: Activation of conventional type 2 dendritic cells (cDC2) by anti-CD47 may enhance antitumor T cell function in mouse liver cancer models

Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancer

Facilitating cholangiocarcinoma inhibition by targeting CD47

Natural Killer Cell Recruitment and Activation Are Regulated by CD47 Expression in the Tumor Microenvironment

Combination CXCR4 and PD1 blockade enhances intratumoral dendritic cell activation and immune responses against hepatocellular carcinoma

Tumor-associated NK cells facilitate tumor growth via NKp46 in immunocompetent murine hepatocellular carcinoma

399P Blocking CD47 and Autophagy for the Therapy of Non-Small-cell Lung Cancer

Targeting the Immune Privilege of Tumor-Initiating Cells to Enhance Cancer Immunotherapy

Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation

Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy

CD47-SIRPα axis blockade in NASH promotes necroptotic hepatocyte clearance by liver macrophages and decreases hepatic fibrosis

Abstract 6510: Irradiation Promotes Hepatocellular Carcinoma Immune Cloaking Via PD-L1 Upregulation Induced by Cgas-Sting Activation

Blocking CX3CR1+ Tumor-Associated Macrophages Enhances the Efficacy of Anti-PD1 Therapy in Hepatocellular Carcinoma.

Irradiation promotes hepatocellular carcinoma immune cloaking via PD-L1 upregulation induced by cGAS-STING activation

Blocking siglec-10hi tumor-associated macrophages improves anti-tumor immunity and enhances immunotherapy for hepatocellular carcinoma

Blocking CX3CR1+ Tumor-associated Macrophages Enhances the Efficacy of Anti-PD-1 Therapy in Hepatocellular Carcinoma